1Mby1M Virtual Accelerator AI Investor Forum: Lisa Chai, General Partner at Interwoven Ventures (Part 1)

Lisa Chai, Co-founder and General Partner at Interwoven Ventures, discusses her firm’s investment thesis.

Building a High Growth Vertical AI Company in Healthcare: Ganesh Padmanabhan, CEO of Autonomize AI (Part 1)

Ganesh has executed on a textbook case study of building a vertical AI company in Healthcare with a clear human-in-the-loop strategy that VCs are salivating over. Read on, much to learn.

Best of Bootstrapping: Bootstrapped a Healthcare Tech Company to $100M

When we spoke in 2015, Edifecs Founder Sunny Singh had built a very interesting healthcare technology company, overcoming serious challenges. Inspiring story of a bootstrapped success.

Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born, raised, and in what kind of background?

Sunny Singh: Give or take, I’ve spent half my life in the US and half my life in India. I grew up in India and finished my undergraduate studies there. Then, I came to the US at the age of 23 to do a couple of Master’s programs. I did three jobs and then started Edifecs in 1996.

>>>

AI Investor Forum: Gus Tai on AI in Healthcare (Part 8)

Sramana Mitra: What is going on in the thought process of the venture capital community vis-a-vis healthcare drug discovery and general AI in the healthcare and life sciences area? When the lean startup movement came about, SaaS was the dominant field in which VCs were investing for maybe even 15 years, the venture capital industry kind of settled into this model that you bootstrapped to some level of validation and then start raising money.

AI Investor Forum: Gus Tai on AI in Healthcare (Part 6)

Sramana Mitra: Some of you here would remember, Gus would definitely remember that many years ago, I came up with a formula for the future of the web. It was called Web 3.0 = (4C + P + VS).

AI Investor Forum: Gus Tai on AI in Healthcare (Part 5)

Sramana Mitra: So, Gus, could you also discuss Joanna Strober’s company that you have invested in and have been tracking for a while? I think it’s a good case study to discuss in this context.

Gus Tai: Absolutely. The company is called Midi Health, and I was a seed investor with Midi. That company is a good illustration of how entrepreneurs, regardless of how they want to think about raising money, can approach industries. There was a latent need and a discontinuity in being able to serve that latent need.

AI Investor Forum: Gus Tai on AI in Healthcare (Part 4)

Sramana Mitra: Yes. On the process side, we’ve had a company become quite successful in the program. It is bootstrapped. We looked at raising money, but eventually, it was going fine as a bootstrapped company. I think it continues to bootstrap. It’s called CliniOps.

AI Investor Forum: Gus Tai on AI in Healthcare (Part 3)

Sramana Mitra: Now, let’s shift to medical imaging, which is another area where AI is having lots of impact. There are lots of companies working in this field, and lots of entrepreneurial efforts going on in this field. The question that I’m of thinking about is that, are these going to be unicorn style opportunities?